Axsome Therapeutics (AXSM)
(Delayed Data from NSDQ)
$94.32 USD
+2.78 (3.04%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $94.32 0.00 (0.00%) 5:34 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -1.36 |
EPS Last Quarter | -1.24 |
Last EPS Surprise | 4.62% |
ABR | 1.11 |
Earnings ESP
|
-4.75% |
---|---|
Current Year | -5.56 |
Next Year | -1.27 |
EPS (TTM) | -4.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 99.21M | 114.17M | 375.68M | 635.85M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 104.39M | 124.75M | 391.30M | 738.14M |
Low Estimate | 93.90M | 103.30M | 359.40M | 469.76M |
Year ago Sales | 57.79M | 71.53M | 270.60M | 375.68M |
Year over Year Growth Est. | 71.67% | 59.60% | 38.83% | 69.25% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.36 | -1.08 | -5.56 | -1.27 |
# of Estimates | 9 | 7 | 11 | 10 |
Most Recent Consensus | -1.42 | -1.26 | -5.71 | -4.22 |
High Estimate | -0.94 | -0.43 | -4.46 | 1.15 |
Low Estimate | -1.55 | -1.37 | -6.64 | -5.05 |
Year ago EPS | -1.32 | -0.73 | -2.67 | -5.56 |
Year over Year Growth Est. | -3.03% | -47.95% | -108.24% | 77.15% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 2 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 7 | 5 | 11 | 9 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.36 | -1.08 | -5.56 | -1.27 |
7 Days Ago | -1.36 | -1.08 | -5.56 | -1.27 |
30 Days Ago | -1.34 | -1.07 | -5.55 | -1.21 |
60 Days Ago | -1.13 | -0.95 | -4.78 | -0.18 |
90 Days Ago | -1.12 | -0.96 | -4.78 | -0.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.42 | -1.26 | -5.71 | -4.22 |
Zacks Consensus Estimate | -1.36 | -1.08 | -5.56 | -1.27 |
Earnings ESP | -4.75% | -16.35% | -2.75% | -232.81% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.24 | -1.09 | -0.73 | -1.32 | NA |
Estimate | -1.30 | -1.20 | -1.21 | -1.24 | NA |
Difference | 0.06 | 0.11 | 0.48 | -0.08 | 0.14 |
Surprise | 4.62% | 9.17% | 39.67% | -6.45% | 11.75% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more